Cargando…
Novel Inhibitors of Nicotinamide-N-Methyltransferase for the Treatment of Metabolic Disorders
Nicotinamide-N-methyltransferase (NNMT) is a cytosolic enzyme catalyzing the transfer of a methyl group from S-adenosyl-methionine (SAM) to nicotinamide (Nam). It is expressed in many tissues including the liver, adipose tissue, and skeletal muscle. Its expression in several cancer cell lines has be...
Autores principales: | Kannt, Aimo, Rajagopal, Sridharan, Hallur, Mahanandeesha S., Swamy, Indu, Kristam, Rajendra, Dhakshinamoorthy, Saravanakumar, Czech, Joerg, Zech, Gernot, Schreuder, Herman, Ruf, Sven |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7918612/ https://www.ncbi.nlm.nih.gov/pubmed/33668468 http://dx.doi.org/10.3390/molecules26040991 |
Ejemplares similares
-
Novel tricyclic small molecule inhibitors of Nicotinamide N-methyltransferase for the treatment of metabolic disorders
por: Ruf, Sven, et al.
Publicado: (2022) -
A small molecule inhibitor of Nicotinamide N-methyltransferase for the treatment of metabolic disorders
por: Kannt, Aimo, et al.
Publicado: (2018) -
Association of nicotinamide-N-methyltransferase mRNA expression in human adipose tissue and the plasma concentration of its product, 1-methylnicotinamide, with insulin resistance
por: Kannt, Aimo, et al.
Publicado: (2015) -
Novel dual LSD1/HDAC6 inhibitor for the treatment of cancer
por: Gajendran, Chandru, et al.
Publicado: (2023) -
Nicotinamide N-Methyltransferase in Health and Cancer
por: Ramsden, David B, et al.
Publicado: (2017)